PerkinElmer Biomedical Announces Board Approval to Change Stock Transfer Agent
PerkinElmer Biomedical Co., Ltd. announced that its board of directors has approved the change of its stock transfer agent from KGI Securities to Taishin Securities, effective October 1, 2026. Shareholders will conduct stock-related procedures with the new agent.
📋 Article Processing Timeline
- 📰 Published: May 5, 2026 at 09:00
- 🔍 Collected: May 6, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 6, 2026 at 08:40 (40 min after Collected)
1. Date of occurrence of the event: 2026/05/05
2. Company name: PerkinElmer Biomedical Co., Ltd.
3. Relationship with the Company (please enter "the Company" or "subsidiary"): The Company
4. Reciprocal shareholding ratio: Not applicable
5. Reason for occurrence: The Company's board of directors resolved to approve the change of the stock transfer agent.
6. Countermeasures: None
7. Other matters that need to be specified (If the event or resolution subject is a public company or above, this material information also complies with Article 7, Paragraph 9 of the Enforcement Rules of the Securities and Exchange Act regarding matters that have a material impact on shareholders' rights or securities prices):
I. The Company's stock affairs were originally handled by the Stock Affairs Agency Department of KGI Securities Co., Ltd. Starting from October 1, 2026, the Company will entrust the Stock Affairs Agency Department of Taishin Securities Co., Ltd. to handle these matters. An application for recordation will be filed with the Taiwan Depository & Clearing Corporation after signing the contract with the new transfer agent.
II. All shareholders of the Company, starting from October 1, 2026, who wish to handle stock transfer, dividend collection, stock collection, address change, stock loss reporting, pledge setting or cancellation, seal change or loss reporting, and other related stock affairs, are requested to proceed in person or by mail to the Stock Affairs Agency Department of Taishin Securities Co., Ltd. The address and contact number and other relevant information are listed below.
Address: B1, No. 96, Section 1, Jianguo North Road, Taipei City
Phone: (02)2504-8125
2. Company name: PerkinElmer Biomedical Co., Ltd.
3. Relationship with the Company (please enter "the Company" or "subsidiary"): The Company
4. Reciprocal shareholding ratio: Not applicable
5. Reason for occurrence: The Company's board of directors resolved to approve the change of the stock transfer agent.
6. Countermeasures: None
7. Other matters that need to be specified (If the event or resolution subject is a public company or above, this material information also complies with Article 7, Paragraph 9 of the Enforcement Rules of the Securities and Exchange Act regarding matters that have a material impact on shareholders' rights or securities prices):
I. The Company's stock affairs were originally handled by the Stock Affairs Agency Department of KGI Securities Co., Ltd. Starting from October 1, 2026, the Company will entrust the Stock Affairs Agency Department of Taishin Securities Co., Ltd. to handle these matters. An application for recordation will be filed with the Taiwan Depository & Clearing Corporation after signing the contract with the new transfer agent.
II. All shareholders of the Company, starting from October 1, 2026, who wish to handle stock transfer, dividend collection, stock collection, address change, stock loss reporting, pledge setting or cancellation, seal change or loss reporting, and other related stock affairs, are requested to proceed in person or by mail to the Stock Affairs Agency Department of Taishin Securities Co., Ltd. The address and contact number and other relevant information are listed below.
Address: B1, No. 96, Section 1, Jianguo North Road, Taipei City
Phone: (02)2504-8125